1-3 of 3
Jeffrey Faint
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Computational Algorithm Based On Serum Immunoassays for the Identification of Haematological Disease May Identify Patients with Other Acute Disorders

David Sutton, Jeffrey Faint, Anandram Seetharam, Alan Macwhannell, Stephen Harding, Abe Jacob, MD, FRCP, FRCPath, Sunil Honda, Ladan Mirbahai, Supratik Basu
Journal: Blood
Blood (2012) 120 (21): 4001.
https://doi.org/10.1182/blood.V120.21.4001.4001
Published: 2012
Journal Articles

Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)

Heinz Ludwig, MD, Jeffrey Faint, Niklas Zojer, Arthur R Bradwell, Philip Young, Dejan Milosavljevic, Wolfgang Hübl, Stephen Harding
Journal: Blood
Blood (2011) 118 (21): 2883.
https://doi.org/10.1182/blood.V118.21.2883.2883
Published: 2011
Journal Articles

Polyclonal Serum FLC Levels: a Simple Risk Stratification Model for Identifying Aggressive Stage A CLL.

Guy Pratt, Alison Levoguer, Jeffrey Faint, Chris Fegan, Chris Pepper, David Graham Oscier, MD, Anne Gardiner, Stephen Harding, PhD
Journal: Blood
Blood (2010) 116 (21): 4608.
https://doi.org/10.1182/blood.V116.21.4608.4608
Published: 2010